SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-291672
Filing Date
2023-12-08
Accepted
2023-12-08 16:06:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d577229d424b3.htm 424B3 572109
2 GRAPHIC g577229dsp1aa.jpg GRAPHIC 6456
3 GRAPHIC g577229g1208035446685.jpg GRAPHIC 3643
4 GRAPHIC g577229g1208042156924.jpg GRAPHIC 3643
  Complete submission text file 0001193125-23-291672.txt   592615
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-273769 | Film No.: 231475434
SIC: 2834 Pharmaceutical Preparations